Speaker(s): 

George Ruiz, MD, MBA, Geisinger - has listed the following disclosures - Actelion Consultant/Advisor
Caroline deRichemond, CRNP, CLS, FNLA - Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Identify opportunities for enhanced CVD prevention through telemedicine and other innovative cardiac care models.
  • Discuss how the COVID-19 pandemic has motivated providers and patients alike to prioritize our health, and how we can leverage this increased health awareness and investment into long-term, meaningful disease prevention.
  • Discuss what the pandemic has taught us about caring for those vulnerable patients who were most afflicted- older adults, person of color, mental illness and people who are facing adverse socioeconomic circumstances- who continue to be impacted by CVD.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO; Stanley Martin, MD; Dan Dometita, DO; Malachi Courtney, MD; Eric Hossler, DO; Stacey Coolbaugh, RDN; and Donald Wieder, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

CE Committee Reviewers: Daniel Davis, PhD and Thomas Davis, MD; have nothing to disclose. 

Session date: 
02/02/2024 - 12:30pm to 1:30pm EST
Location: 
Microsoft Teams Meeting
Danville, PA 17822
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 CDR
  • 1.00 Participation Credit

Please login or register to take this course.